Feagan BG, Matsuoka K, Rogler G, Laharie D, Vermeire S, Danese S, Loftus EV Jr, Beales I, Schreiber S, Kim HJ, et al. Long-term safety and efficacy of filgotinib for the treatment of moderately to severely active ulcerative colitis: Interim analysis from up to 4 years of follow-up in the SELECTION open-label long-term extension study. Alimentary pharmacology & therapeutics. 2024. 60. 5. 563-584
Matsuoka K, Inoue T, Tsuchiya H, Nagano K, Iwahori T. Association between oral corticosteroid starting dose and the incidence of pneumonia in Japanese patients with ulcerative colitis: a nation-wide claims database study. Intestinal Research. 2024. 22. 3. 319-335
ukuda T, Yamazaki H, Miyatani Y, Sawada T, Shibuya N, Fukuo Y, Kiyohara H, Morikubo H, Tominaga K, Kakimoto K, et al. Recent steroid use and the relapse risk in ulcerative colitis patients with endoscopic healing. Alimentary pharmacology & therapeutics. 2024. 60. 1. 43-51
Makuuchi M, Kakuta Y, Umeno J, Fujii T, Takagawa T, Ibuka T, Miura M, Sasaki Y, Takahashi S, Nakase H, et al. Real-world NUDT15 genotyping and thiopurine treatment optimization in inflammatory bowel disease: a multicenter study. Journal of Gastroenterology. 2024. 59. 6. 468-482